UIC named NIH Islet Cell Resource Center

December 19, 2006

The University of Illinois at Chicago has been named a National Institutes of Health Islet Cell Resource Center and awarded a three-year $3.25 million grant.

One of seven federally funded centers in the United States, UIC will provide researchers across the country with human pancreatic islet cells for transplantation into diabetic patients and provide cells for basic science research.

"We will also conduct research and develop ways to improve cell isolation techniques, cellular viability and functioning, and shipping procedures for islet cells," said José Oberholzer, principal investigator and director of cell and pancreas transplantation at UIC.

Working in collaboration with other islet resource centers, UIC will test and implement standardized methods for assessing islets to determine what factors may predict a successful islet transplant.

Insulin-producing islet cells from cadaveric donor pancreases are isolated and processed in a state-of-the-art, FDA-approved laboratory at the medical center.

The laboratory has provided islet cells for successful transplantation in patients at the medical center and has also shipped islets to institutions in the United States and Europe.

Islet cell transplantation allows patients with type-1 diabetes to achieve insulin independence, glucose control and freedom from hypoglycemic attacks, according to Oberholzer. Transplantation offers the most promise for achieving a functional cure for diabetes, but it also has limitations.

One shortcoming is the lack of organ donors. There are only 6,000 donor pancreases each year in the United States and each organ can only produce enough islets to help, at most, one diabetic.

Transplant recipients must also take drugs to suppress their immune system in order to avoid rejection of the islets.

"There are 20.8 million diabetic patients in the United States," said Oberholzer, "and most of them could benefit from an islet transplant if an unlimited source of cells was available and if the cells could be protected from rejection by a better means than the current immunosuppression."

Oberholzer and a team of international researchers have formed the Chicago Project, a collaboration of top scientists who are committed to helping diabetics worldwide by developing a cell-based cure for diabetes in the next five years. The Chicago Project aims to develop an unlimited supply of islet cells from donor pancreases and find a way to encapsulate the cells to prevent rejection.

"Becoming an NIH-funded Islet Resource Center will enhance our efforts to find a functional, or cell-based, cure for diabetes," said Oberholzer. "Clinicans and researchers at other centers will also benefit by having high-quality islets procured, processed and distributed by a core facility with the highest standards."

Part of UIC's grant will fund scientific research at Northwestern University to improve the technology for evaluating the quality of islets.
-end-
UIC ranks among the nation's top 50 universities in federal research funding and is Chicago's largest university with 25,000 students, 12,000 faculty and staff, 15 colleges and the state's major public medical center. A hallmark of the campus is the Great Cities Commitment, through which UIC faculty, students and staff engage with community, corporate, foundation and government partners in hundreds of programs to improve the quality of life in metropolitan areas around the world.

For more information about UIC, visit www.uic.edu

University of Illinois at Chicago

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.